Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Generation of Induced Pluripotent Stem Cells from Amniotic Fluid Cells of a Fetus with Hb Bart's Disease.

Hemoglobin - 1 May 2017

Yan Jin-Mei, Li Dong-Zhi

Abstract excerpt

Induced pluripotent stem cells (iPSCs) derived from diseased patients behave as a powerful tool for biomedical research and may provide a source for replacement therapies. In this study, we generated iPSCs from amniotic fluid cells of a fetus with Hb Bart's (γ4) disease (- -/- -). The established iPSCs showed pluripotency similar to that of human embryonic stem cells. They were able to differentiate into various...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Karyotype
Share to alpha-Thalassemia
Share to Amniotic Fluid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cellular Reprogramming

Share to Hemoglobins, Abnormal

Share to Homozygote

Share to Induced Pluripotent Stem Cells

Share to Sequence Deletion

Source

Identifiers

PMID: 28835139
DOI: 10.1080/03630269.2017.1353523

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Generation of Induced Pluripotent Stem Cells from Amniotic Fluid Cells of a Fetus with Hb Bart's Disease.PMID 28835139Read ↗

Generation of a human iPSC line CIBi008-A from amniotic fluid-derived cells of a fetus with β-thalassemia carrying variants of -28A > G and IVS-II-654C > T in HBB.Semantic proximity Read ↗

Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders.Semantic proximity Read ↗

Generation of Human Induced Pluripotent Stem Cells from Extraembryonic Tissues of Fetuses Affected by Monogenic DiseasesSemantic proximity Read ↗

Generation of human induced pluripotent stem cells from a patient with Beckwith-Wiedemann syndromeSemantic proximity Read ↗

Generation of four induced pluripotent stem cell lines (FHUi003-A, FHUi003-B, FHUi004-A and FHUi004-B) from two affected individuals of a familial neurohypophyseal diabetes insipidus family.Semantic proximity Read ↗

Modeling blood diseases with human induced pluripotent stem cellsSemantic proximity Read ↗

High efficiency of reprogramming CD34⁺ cells derived from human amniotic fluid into induced pluripotent stem cells with Oct4.Semantic proximity Read ↗

Induced pluripotent stem (iPS) cells from human fetal stem cells (hFSCs)Semantic proximity Read ↗

Stem Cells in Amniotic Fluid as New Tools to Study Human Genetic DiseasesSemantic proximity Read ↗

Generation of nine iPSC lines (HNMUi002-A, HNMUi003-A, HNMUi004-A, HNMUi005-A, HNMUi006-A, HNMUi007-A, HNMUi008-A, HNMUi009-A, HNMUi010-A) from three Chinese families with thalassemia.Semantic proximity Read ↗

Generation of an induced pluripotent stem cell line from a Bartter syndrome patient with the homozygote mutation p.A244D (c.731C>A) in SLC12A1 gene.Semantic proximity Read ↗

Derivation of a human induced pluripotent stem cell line (QBRIi007-A) from a patient carrying a homozygous intronic mutation (c.613-7T>G) in the SLC2A2 gene.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.